---

Market Overview

---

The global pharmaceutical aseptic transfer market is projected to reach $2,552 million by 2031, with a compound annual growth rate (CAGR) of 9.61% during the forecast period of 2022-2031. This growth can be attributed to several factors, including the expansion of the pharmaceutical industry, increased investment in the sector, stricter regulations for drug approval processes, and the growing demand for automated products for aseptic transfer.

The market encompasses products and systems that facilitate the aseptic transfer of drugs and pharmaceutical products throughout the drug development cycle, from research and development to packaging and distribution. Over time, regulations governing the maintenance of an aseptic environment have become more stringent, especially for high-potency drugs. Market players offer various types of products for aseptic transfer, such as isolators, restricted access barrier systems (RABS), laminar air flow (LAF) trolleys, portbags, rapid transfer ports, sterile connectors, and tubing. They are also aligning their product portfolios with market trends, including the use of single-use technology (SUT) systems.

Opportunities in the market include the increasing demand for single-use aseptic transfer systems, liquid aseptic transfer systems, and the integration of Industry 4.0 within the pharmaceutical aseptic industry. Key trends include the shift from conventional cleanroom technology to barrier technology, the development of single-use transfer solutions, the rising demand for genderless aseptic connectors, and increased mergers and acquisitions (M&As) among market players.

The COVID-19 pandemic led to significant investments in research and development by pharmaceutical companies, resulting in increased production of drugs for COVID-19. The urgent need to meet this demand quickly and meet regulatory standards led to a higher demand for maintaining an aseptic environment. However, trade and travel restrictions posed challenges to the supply chain, making it more difficult to procure components and systems. Despite these challenges, the high demand for aseptic solutions offset the negative impact and resulted in market growth in 2020 and 2021.

Driving factors for the global pharmaceutical aseptic transfer market include the rapid expansion of the pharmaceutical industry, increased investment in the sector, stricter regulations for drug approval processes, and growing demand for automated products for aseptic transfer processes. However, the market also faces limitations such as the complex development cycle of aseptic transfer systems, requiring significant capital investment for installation, a lack of skilled personnel, and a growing preference for refurbished equipment.

---

Market Segmentation

---

The market is segmented based on various factors, including system type, usability, transfer type, end user, and region.

Segmentation by System Type
Liquid Transfer System
Solid Transfer System

Segmentation by Usability
Single-Use
Multiple-Use

Segmentation by Transfer Type
Port
Portbags
Others

Segmentation by End User
Pharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMOs)
Others

Segmentation by Region
North America – U.S., Canada
Europe – Germany, France, U.K., Italy, Spain, Rest-of-Europe
Asia-Pacific – Japan, China, India, Australia, South Korea, Rest-of-Asia-Pacific
Latin America – Brazil, Mexico, Rest-of-Latin America
Middle East and Africa – U.A.E., South Africa, Rest-of-Middle East and Africa

The solid transfer system segment is projected to dominate the global pharmaceutical aseptic transfer market (by system type). In 2021, this segment accounted for a value of $542 million and is expected to reach $1,552 million by the end of 2031, with a compound annual growth rate (CAGR) of 9.15% during the forecast period of 2022-2031.

The multiple-use segment holds the dominant position in the global pharmaceutical aseptic transfer market (by usability). The increasing demand for single-use components is an important trend shaping the market. According to an article published in the American Pharmaceutical Review in October 2018, titled Biopharmaceutical Manufacturing is Shifting to Single-Use Systems. Are the Dinosaurs, the Large Stainless-Steel Facilities, Becoming Extinct? projections from the BioPlan Associates’ 15th Annual Survey on Biopharmaceutical Manufacturing Capacity and Production indicate that while stainless steel containers will still be used for high-volume products, single-use systems will dominate the biopharmaceutical industry at the clinical scale.

The others segment dominates the global pharmaceutical aseptic transfer market (by transfer type). This segment includes isolators, accessories, transfer carts, tubing caps, bio containers, and bioprocessing. Isolation technology is utilized for applications such as sterility testing, fill lines, and other advanced aseptic applications, including aseptic containment systems.

Among the various end users, the pharmaceutical companies segment holds the largest share in the global pharmaceutical aseptic transfer market. In 2021, pharmaceutical companies and contract development and manufacturing organizations (CDMOs) collectively accounted for over 80% of the market share. The pharmaceutical companies segment held a 57.30% share in 2021 and is expected to witness robust growth with a CAGR of 8.92% during the forecast period of 2022-2031. This growth is primarily driven by the rapid expansion of the pharmaceutical industry and increased investment in the segment. Additionally, CDMOs are projected to grow at a CAGR of 10.71% during the forecast period, reaching $809 million by the end of 2031.

North America and Europe, home to major pharmaceutical companies and prominent CDMOs, hold the largest market share in the global pharmaceutical aseptic transfer market. The Asia-Pacific region is expected to experience significant growth during the forecast period of 2022-2031, driven by factors such as increased R&D investment in the pharmaceutical industry and growing awareness of the importance of aseptic transfer solutions in maintaining the quality and sterility of manufactured drugs.

---

Competitive Landscape

---

The selection of the profiled companies was based on inputs obtained from primary experts, as well as an analysis of their company coverage, product portfolio, and market penetration.

Key companies profiled in this report include ABC Transfer SAS, ATS Automation Tooling Systems, Inc., Azbil Corporation, Castus GmbH & Co. KG, ChargePoint Technology, Dover Corporation, EnPro Industries, Inc., Entegris Inc., Ezi-Dock Systems Ltd., Getinge AB, ILC Dover LP, JCE Biotechnology, Rommelag, Sartorius AG, Single Use Support GmbH.

---

Recent Industry Developments

---

In June 2022, ChargePoint Technology completed the acquisition of Terracon, a manufacturer specializing in single-use products and accessories.

In January 2022, ChargePoint Technology expedited its expansion efforts to enhance services in the U.S. market.

In June 2022, Getinge AB introduced DPTE-EXO, featuring a sleeveless DPTE-BetaBag, aimed at facilitating automated aseptic transfer and improving operational efficiency.

In November 2021, Getinge AB expanded its presence in Vietnam by establishing its authorized unit, Getinge Vietnam.

In November 2021, Sartorius AG expanded its production capacities in France to cater to the growing demands of the pharmaceutical industry, particularly in storage and innovation.

In September 2021, Sartorius AG expanded its manufacturing facilities in China, focusing on biological drug discovery, process development, testing, and validation, in response to the increasing local customer demand.

In March 2021, Arcline Investment Management acquired ChargePoint Technology, paving the way for an enhanced global presence.

In January 2021, Getinge AB expanded the production capacity of its DPTE BetaBags in the U.S. by initiating manufacturing at its facility in Merrimack, New Hampshire.

In December 2020, Pall Corporation established a strategic partnership with Single Use Support GmbH to globally distribute the RoSS SHELL platform developed by the latter.

In June 2020, ABS Transfer SAS secured $3.2 million (€3 million) in a series A funding round led by Go Capital, along with participation from Bpifrance and the regional government of Centre-Val de Loire.

---

Key Questions Answered

---

What are the primary market drivers, challenges, and opportunities in the global pharmaceutical aseptic transfer market?

What are the emerging trends within the global pharmaceutical aseptic transfer market?

How is the global pharmaceutical aseptic transfer market segmented by system type, usability, transfer type, region, and end user?

What is the expected growth of each segment in the global pharmaceutical aseptic transfer market during the forecast period? What is the anticipated revenue generated by each segment by the end of 2031?

What are the significant strategies implemented by major players to sustain their competitiveness in the market? Which regulatory bodies control the entry of aseptic transfer products into the market?

Who are the leading players with substantial offerings in the global pharmaceutical aseptic transfer market? What is the current market dominance of each of these leading players?

What is the expected compound annual growth rate (CAGR) for the leading players in the market during the forecast period of 2022-2031? Which system type is expected to have the most promising growth?

Who are the key manufacturers in the global pharmaceutical aseptic transfer market and what are their contributions?

What is the growth potential of the global pharmaceutical aseptic transfer market in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa?

What is the trend in patent filings in the global pharmaceutical aseptic transfer market?